This post was originally published on this site
The once red-hot vape company has also been working with its legal advisers on options that include a possible bankruptcy filing if it is unable to get relief from the government’s ban, the Wall Street Journal reported on Friday, citing people familiar with the matter. (https://on.wsj.com/3zZKXiz)
The FDA said on Thursday Juul failed to show that the sale of its products would be appropriate for public health, following a nearly two-year-long review of data provided by the company. Juul said it disagreed with the agency’s findings.
In a filing with the U.S. Court of Appeals for the District Of Columbia Circuit, Juul asked for an administrative stay until the company can file a full briefing for an emergency review.
The FDA declined to comment on Juul’s filing, while Juul did not immediately respond to a request for comment.
Juul said the FDA’s decision to block sales of its products was “extraordinary and unlawful”, citing, among other things, the agency authorizing similar e-cigarette products made by competing manufacturers.
BAT (LON:BATS)’s Vuse Solo was the first e-cigarette to get the agency’s clearance in October.
